An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank that represents shares of a foreign company.

Trading or Investing in Immatics N.v. (NASDAQ: IMTX) involves an observation of the technicals, every time. This data reveals the current technicals. This is a static report, the data below was valid ...

"ESMO 2024: BMS cuts ties as Immatics regains full rights to bispecific" was originally created and published by ...

Bristol Myers Squibb is ending its collaboration with Immatics on IMA401, effective December 12, as part of portfolio ...

Bristol Myers Squibb presented the positive Phase III results on its already approved Opdivo-Yervoy combo at ESMO over the ...

Immatics presented more clinical data on its bispecific T cell engager at Europe's largest cancer conference. But the German and US biotech is losing its partner on the Phase 1 drug, which became one ...

Bristol Myers Squibb has jettisoned another cancer candidate in-licensed under its former CEO. Immatics is the latest partner ...

Leerink Partners analyst Jonathan Chang maintained a Buy rating on Immatics (IMTX – Research Report) on September 8. The company’s ...

Immatics’ PRAME peptide is present at a high copy number per tumor cell and is homogeneously and specifically expressed in tumor tissue. The peptide has been identified and characterized by Immatics’ ...

Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery ...

Immatics’ PRAME peptide is present at a high copy number per tumor cell and is homogeneously and specifically expressed in tumor tissue. The peptide has been identified and characterized by ...